Feladilimab [2252518-85-5]

TargetMol Chemicals

Feladilimab

9

Antibody

Research Use Only

Feladilimab

SDS-PAGE:95% SEC-HPLC:98%

Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNgamma, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.

3 years

-20°C

12352203